Analyst firms · J.P. Morgan · VRNS

J.P. Morgan VRNS price target and rating history

Varonis Systems Inc. (VRNS) · Technology

J.P. Morgan rates Varonis Systems Inc. (VRNS) Overweight with a $54 price target, as of its latest action on Jun 14, 2024. It has published 3 rating actions on VRNS since January 2023, including 2 upgrades and 0 downgrades. Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50.

Current rating
Overweight
Price target
$54
Median target, all firms
$45.50
Actions on VRNS
3

J.P. Morgan price target on VRNS

$54$40$25202420252026
J.P. Morgan price target on VRNS, each point a stated target, January 2023 to June 2024.

Every J.P. Morgan rating on VRNS

How other firms rate VRNS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
SusquehannaNeutral$49.75Nov 5, 2026
StephensEqual-Weight$45Oct 27, 2026
BarclaysEqual Weight$50Oct 19, 2026
WedbushNeutral$46Sep 11, 2026
KeyBanc Capital MarketsSector WeightMay 26, 2026
William BlairMkt PerformMar 23, 2026
Wells FargoOverweight$28Mar 3, 2026
DA DavidsonBuy$30Feb 5, 2026
Morgan StanleyEqual-Weight$41Jan 26, 2026
Piper SandlerOverweight$47Jan 5, 2026

Questions about J.P. Morgan and VRNS

What is J.P. Morgan's price target for VRNS?
J.P. Morgan's latest stated price target for Varonis Systems Inc. (VRNS) is $54, from its action on Jun 14, 2024.
What is J.P. Morgan's rating on VRNS?
J.P. Morgan rates VRNS Overweight, a bullish rating, as of Jun 14, 2024.
When did J.P. Morgan last change its view on VRNS?
On Jun 14, 2024, J.P. Morgan upgrades to Overweight from Neutral, price target $50 to $54.
How does J.P. Morgan's VRNS target compare with other analysts?
Across 8 firms with a VRNS price target in the last 12 months, the median target is $45.50.

More VRNS rating histories

All J.P. Morgan ratingsVRNS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.